Peregrine Asset Advisers, Inc. Bristol Myers Squibb CO Transaction History
Peregrine Asset Advisers, Inc.
- $293 Million
- Q2 2025
A detailed history of Peregrine Asset Advisers, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Peregrine Asset Advisers, Inc. holds 19,726 shares of BMY stock, worth $878,596. This represents 0.31% of its overall portfolio holdings.
Number of Shares
19,726
Previous 19,826
0.5%
Holding current value
$878,596
Previous $1.21 Million
24.48%
% of portfolio
0.31%
Previous 0.5%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...